Researchers examined the outcomes of 371 peritoneal dialysis patients that had either antibacterial honey or the more standard intranasal mupirocin prophylaxis applied to the catheter exit site.
There was little difference in outcomes between the treatments, showing honey to be effective in preventing infections. The researchers suggested that while mupirocin is probably the best option for most patients, the honey could be useful for patients known to be infected with murpirocin-resistant organisms or who have an allergy to murpirocin.
More Articles on Infection Prevention:
Wisconsin Hospitals Reduce CLABSIs, CAUTIs
Study: Hand Hygiene Improvement Didn’t Decrease 2 HAIs
Study: Men at Higher Risk for Bloodstream, Surgical Site Infections
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
